Machine signal
Active cluster buy — 8 distinct insiders, $551K, window ends Aug 14, 2026.
Figures computed from official regulatory filings — .
Analysttarget 5.83 USD (+7%) · consensus 3.33/5 · 1 buy · 2 hold · 0 sell
Ownershipinsiders 6.13% · institutions 38.87% · short 0.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for EDAP TMS SA only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
9 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| WILLSEY LANCEtrack record | Buy | $237.5K | conv 63 |
| SEC |
| Horn David R. | Buy | $47.5K | conv 80ClusterFirst in 12mo | SEC |
| Schulz Fran | Buy | $47.5K | conv 89ClusterFirst in 12mo | SEC |
| Shah Sanket | Buy | $23.8K | conv 64ClusterFirst in 12mo | SEC |
| Annen Steven | Buy | $23.8K | conv 63ClusterFirst in 12mo | SEC |
| LEVINE JOSHUAtrack record | Buy | $47.5K | conv 47Cluster | SEC |
| Mobeck Kenneth S. | Buy | $23.8K | conv 69ClusterFirst in 12mo | SEC |
| Rhodes Ryan | Buy | $99.8K | conv 67ClusterFirst in 12mo | SEC |
| Rhodes Ryan | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rhodes Ryan | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILLSEY LANCEtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mobeck Kenneth S. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mobeck Kenneth S. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Shah Sanket | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| LEVINE JOSHUAtrack record | Buy | $42.2K | conv 47First in 12mo | SEC |
| Annen Steven | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Shah Sanket | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Annen Steven | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |